A synthetic antibiotic class overcoming bacterial multidrug resistance
Matthew J. Mitcheltree(Harvard University), Andrew G. Myers(Harvard University), Daniel W. Terwilliger(Harvard University), Dorota Klepacki(University of Illinois Chicago), Amarnath Pisipati(Harvard University), Yury S. Polikanov(University of Illinois Chicago), Kelvin J. Y. Wu(Harvard University), Katherine J. Silvestre(Harvard University), Egor A. Syroegin(University of Illinois Chicago), Richard Porter Ladley(Harvard University), Kelly Chatman(Harvard University Press), Aditya R. Pote(Harvard University), Jeremy D. Mason(Harvard University), Giambattista Testolin(Harvard University), Alexander S. Mankin(University of Illinois Chicago)
Cited by 230
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Preparation of the Reagent <i>o</i>-Nitrobenzenesulfonylhydrazide
|The Journal of Organic Chemistry|1997|179
Synthesis of highly epimerizable N-protected α-amino aldehydes of high enantiomeric excess
|Tetrahedron Letters|2000|101